3535 results for «2025年12月15日市值50-100亿服务消费股票推荐»

Filter By

3535 results

Pivotal study on the ShortCut transcatheter aortic valve leaflet splitting device

16 May 2024

Coronary obstruction is a major concern in patients undergoing TAVI for degenerated bioprostheses (valve-in-valve [ViV]) and is associated with a 30-day mortality rate of around 50%.1 While several transcatheter techniques to lacerate bioprosthetic valve leaflets prior to TAVI placement (such as BASILICA) have been described, they are...

Pivotal study on the ShortCut transcatheter aortic valve leaflet splitting device

Case report: Renal denervation using ultrasound energy (uRDN)

23 Oct 2024

In this case report, we examine an advanced technique for renal denervation (RDN)—ultrasound energy—employed to manage severe hypertension in patients with complex medical histories.

Joachim Weil

Author

Joachim Weil
Case report: Renal denervation using ultrasound energy (uRDN)

COVID-19: safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine (Sputnik V)

18 Feb 2021

Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability

COVID-19: safety and efficacy of the Sputnik V vaccine

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease.

25 Apr 2023

Recruitment complete in BEVAR study for on-label use of the Bentley BeGraft peripheral PLUS as a bridging stent

10 Mar 2023

Hypertension management in 2022: Latest data on renal denervation - EuroPCR 2022

17 May 2022

On the occasion of World Hypertension Day, Felix Mahfoud speaks about the value of renal denervation, including the latest data and what we can learn about renal denervation at EuroPCR 2022.

Author

Felix Mahfoud
Hypertension management in 2022: Latest data on renal denervation

STOPDAPT-2 ACS: exploring the limits of short DAPT

31 Aug 2021

Hirotoshi Watanabe (Kyoto, Japan) presented the results of the STOPDAPT-2 ACS trial in a Hot Line session of the ESC Congress 2021. Dejan Milasinovic provides his analysis of this study.

Dejan Milasinovic

Author

Dejan Milasinovic
ESC Congress 2021 - STOPDAPT-2 ACS: exploring the limits of short DAPT

Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent

21 Jul 2022

TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation

31 Mar 2026

Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Jonathan Curio

Author

Jonathan Curio
TRISCEND II: Two-Year Outcomes Of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation

2024 ESC Guidelines: Peripheral arterial and aortic diseases - Focus on Peripheral Arterial Diseases

09 Sep 2024

The 2024 ESC Guidelines for aortic diseases, merged with peripheral arterial disease guidelines, update prior guidance and emphasize atherosclerotic conditions. In this article, Antoine Sauguet summarizes the content related to peripheral arterial diseases.

Dr. Antoine Sauguet

Author

Antoine Sauguet
2024 ESC Guidelines: Peripheral arterial and aortic diseases - Focus on Peripheral Arterial Diseases

EuroPCR 2024: Primary outcomes from PINNACLE I clinical trial establish safety and effectiveness of Elixir Medical’s Hertz Contact Intravascular Lithotripsy System for calcium fragmentation in moderate to severe calcified coronary artery lesions

16 May 2024

Robocath demonstrates feasibility of robotic carotid stenting in ‘CARE’ clinical trial conducted at Rennes University Hospital

19 Oct 2023

Bentley acquired the GoBack catheter

13 Sep 2022

EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)

17 May 2023

EuroPCR 2021 - Unprecedented global outreach and online interactivity during an innovative livestreamed edition

25 May 2021

Paris, France. 21 May 2021.  Since 1989, EuroPCR has constantly pioneered innovative educational tools and formats to help the interventional cardiovascular community effectively share their knowledge, skills and practice. Rising up to the challenge of the pandemic, the 31st annual edition was fundamentally rethought, reshaped and...

EuroPCR 2021

Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

01 Sep 2022

Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...

Daniele Giacoppo

Author

Daniele Giacoppo
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

31 Mar 2025

Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial

How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR

09 Mar 2026

Recurrent mitral regurgitation after M-TEER can create a challenging scenario. Discover the ELASTA-Clip technique and its key steps to enable TMVR!

Jonathan Curio

Author

Jonathan Curio

Author

Matti Adam
How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR

Vascular robotics: Robocath unveils survey findings on users’ current expectations and future developments

15 May 2024

Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism: primary outcomes from the PEERLESS randomized controlled trial

30 Oct 2024

Elad Asher provides his take on the PEERLESS trial presented by Wissam A. Jaber at TCT 2024 in Washington.

Elad Asher

Author

Elad Asher
Large-bore mechanical thrombectomy vs catheter-directed thrombolysis for treatment of intermediate-risk pulmonary embolism
Didn’t find what you were looking for?